Quest Diagnostics offers one of the most comprehensive pharmacogenomics test panels available to help you gain insight into a patient’s potential response to medications and optimize their treatment considerations and outcomes. This includes information for over 280 drugs across 44 genes*. This full panel is particularly advantageous for patients on multiple medications who may otherwise require multiple panels—all at a low cost and coming from a company you trust to meet all of your lab needs.

The Pharmacogenomics Panel from Quest provides pharmacogenetic information for 44 genes, and reports information across multiple specialties:

  • Anesthesia
  • Cancer/Hematology
  • Cardiovascular
  • Diabetes
  • Gastrointestinal
  • Gaucher Disease

  • Infectious Disease
  • Neurology
  • Pain
  • Psychiatry and Addiction
  • Rheumatology
  • Urologicals

Physicians receive test results in a comprehensive and easy to understand report that may include dosing guidelines from CPIC®, the FDA, and other pharmacogenomic consortium when available. Results can be utilized as a reference for your patients throughout their lifetime.

See the Drugs
Download the PGx brochure
See the Genes
Download the PGx reference guide

Call 1.866.GENE.INFO (1.866.436.3463) or email GeneInfo@QuestDiagnostics.com today for information about any of the solutions above. If calling from outside the US call 1.678.406.1198.

Pharmacogenetics/pharmacogenomics (PGx) is the study of how inherited genetic differences impact the way drugs or medications affect a person. These genetic differences can impact the way a drug is absorbed or metabolized and thereby influence drug response. Pharmacogenomic tests may provide information about a person’s genetic makeup to help doctors decide which medications and doses might work best for him or her. Pharmacogenomic testing can also help reduce the time and costs associated with a trial-and-error approach to treatment.1

Avoiding adverse drug reactions can make a difference

2
Million

adverse drug reactions annually2

1
Million

ER visits due to adverse drug reactions3

100
k

fatalities due to adverse drug reactions4

The Pharmacogenomics Panel from Quest provides pharmacogenetic information for 44 genes, and reports information on over 280 commercial drugs across multiple classes of medication.

The panel may determine:

  • Risk of adverse drug reaction
  • Efficacy (i.e., will it work?)

Consider ordering a Pharmacogenomics Panel:

  • Prior to starting a specific drug therapy with common significant adverse effects
  • If a person has started taking a drug and is experiencing side effects
  • If a clinician is having trouble establishing and/or maintaining a stable dose of a drug
  • For patients on multiple medications

See the Drugs

Test code: 36943

Test name: Pharmacogenomics Panel

Sample specifications: for whole blood - optimum: 5.0 mL, minimum: 2.0 mL

Preferred specimen*: whole blood in EDTA lavender top tube, saliva #200935 and buccal swabs #200944 are also acceptable

Turnaround time: 7-14 days

We accept blood,
saliva, and buccal

Specimen stability:

Whole blood:
Room temperature: 30 days
Refridgerated: 8 days
Frozen: Unacceptable

Buccal:
Room temperature: 30 days
Refridgerated: 30 days
Frozen: 30 days

Saliva:
Room temperature: 30 days
Refridgerated: 30 days
Frozen: 30 days

CPT Codes*: 81225, 81226, 81227, 81230, 81232, 81247, 81283, 81291, 81328, 81335, 81350, 81355, 81381(x4), 81400, 81479

Ordering steps

  1. Order the Pharmacogenomics Panel in 1 of 3 ways
    • Paper requisition*
    • Electronic ordering using Quanum™ eLabs
    • An interfaced EMR*Get copies of the paper Pharmacogenomics requisition from your Quest Diagnostics account manager.

  2. Collect the patient specimen in the office and send with the requisition by a Quest Diagnostics courier, or send the patient to one of our more than 2,220 Patient Service Centers with the requisition to have the specimen collected.
    • Acceptable specimen types are blood (preferred), buccal, and saliva
    • Collection devices can be obtained by calling customer service or online with Quanum™ eLabs
    • Patient Service Center will collect blood sample

*DNA will be extracted from the sample and tested for changes in multiple genes.

**The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Download the PGx brochure
Download the PGx reference guide

Call 1.866.GENE.INFO (1.866.436.3463) or email GeneInfo@QuestDiagnostics.com today for information about any of the solutions above. If calling from outside the US call 1.678.406.1198.

Quest Diagnostics wants to make sure as many patients as possible can take advantage of the benefits of pharmacogenomics testing.

  • We are in network with most major insurance companies
  • We offer financial assistance to patients who qualify
  • We have more than 2,200 Patient Service Centers across the US

Stay in Touch

To stay up to date with the latest in pharmacogenomics and other initiatives, please fill out the form below:

Quest Diagnostics is committed to protecting your privacy while advancing healthcare and empowering better patient health. For additional details on our privacy policy, please click here. We respect your right to control your data. Click here to share your communication preferences.

This list is intended for health care professionals in the USA.

Thank you

We will keep you updated!

* Pharmacogenomic information is not assessed for potential alternative medications. These data are provided as alternatives to consider based on information reported in the literature due to pharmacogenomic contraindications in other medications.

The information provided herein and in the pharmacogenetics report is for physician consideration and each physician has to determine what is the best treatment for their patient based upon the physician’s education, experience and clinical assessment of the patient

References

  1. Elliott LS, Henderson JC, Neradilek MB, Moyer NA, Ashcraft KC, Thirumaran RK. Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: a prospective pilot randomized controlled trial. PLoS One. 2017;12(2):e0170905. doi: 10.1371/journal.pone.0170905
  2. US Food & Drug Administration (FDA). Preventable adverse drug reactions: a focus on drug interactions. https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm110632.htm. Updated March 6, 2018. Accessed December 4, 2018.
  3. Office of Disease Prevention and Health Promotion. Adverse drug events overview. https://health.gov/hcq/ade.asp. Updated December 7, 2017. Accessed December 4, 2018.
  4. Personalized Medicine Project. Section 1: basics of personalized medicine. http://personalizedmedicineproject.weebly.com/section-1-basics-of-personalized-medicine.html. Accessed December 4, 2018.

Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks — ® and TM — are the property of their respective owners.

©2019 Quest Diagnostics Incorporated. All rights reserved.

Image content features models and is intended for illustrative purposes only.